<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
    <style>
        *{
            margin: 0;
            padding: 0;
            list-style: none;
            text-decoration: none;
        }
body{
width: 100vw;
height: 100vh;
}
.tp{
width: 100vw;
height: 10vh;
background-color: #98b6ec;
position: fixed;
top: 0;
left: 0;
opacity: 0.9;
}
.sym img{
width: 5vw;
height: 10vh;
float: left;
}
.menu{
float: right;
position: fixed;
right: 5vw;
top: 2vh;
width: 15vw;
cursor: pointer;
z-index: 1;
height: 30vh;
}
.b1{
float: left;
font-size: 3vmax;
color: white;
font-size: 2.5vmax;
font-family: Verdana, Geneva, Tahoma, sans-serif;
font-weight: 600;
}
.b2{
float: left;
margin-left: 2vw;
}
input[type = "checkbox"] {
  -webkit-appearance: none;
  display: none;
  visibility: hidden;
}
.bar {
  display: block;
  position: relative;
  cursor: pointer;
  width: 50px;
  height: 40px;
}
.bar span {
  position: absolute;
  width: 45px;
  height: 7px;
  background: #f1faee;
  border-radius: 100px;
  display: inline-block;
  transition: 0.3s ease;
  left: 0;
}
.bar span.top {
  top: 0;
}
.bar span.middle {
  top: 17px;
}
.bar span.bottom {
  bottom: 0;
}
input[type]:checked ~ span.top {
  transform: rotate(45deg);
  transform-origin: top left;
  width: 48px;
  left: 5px;
}
input[type]:checked ~ span.bottom {
  transform: rotate(-45deg);
  transform-origin: top left;
  width: 48px;
  bottom: -1px;
  box-shadow: 0 0 10px #495057;
}

input[type]:checked ~ span.middle {
  transform: translateX(-20px);
  opacity: 0;
}
.cai{
  background-color: grey;
  position:fixed;
  width: 15vw;
  height: 36vh;
  opacity: 0;
  z-index: 1;
  margin-top: 8vh;
  border-radius: 10px;
}
.cai li{
  text-align: center;
  height: 4vh;
}
.but{
 width: 15vw;
 height:4vh;
 background: grey;
 border: none;
 border-radius: 5px;
 font-weight: bold;
 cursor: pointer;
 position: relative;
 z-index: 1;
 overflow: hidden;
}
.but a{
  color: white;
  font-size: 1.5vmax;
}
button a:hover {
 color: grey;
}

button:after {
 content: "";
 background: white;
 position: absolute;
 z-index: -1;
 left: -20%;
 right: -20%;
 top: 0;
 bottom: 0;
 transform: skewX(-45deg) scale(0, 1);
 transition: all 0.5s;
}

button:hover:after {
 transform: skewX(-45deg) scale(1, 1);
 -webkit-transition: all 0.5s;
 transition: all 0.5s;
}

.menu:hover .cai{
 opacity: 0.7;
 transition: 0.5s;
}
.loader {
 position: relative;
 width: 2.5em;
 height: 2.5em;
 transform: rotate(165deg);
}
.loader:before, .loader:after {
 content: "";
 position: absolute;
 top: 50%;
 left: 50%;
 display: block;
 width: 0.5em;
 height: 0.5em;
 border-radius: 0.25em;
 transform: translate(-50%, -50%);
}
.loader:before {
 animation: before8 2s infinite;
}
.loader:after {
 animation: after6 2s infinite;
}
@keyframes before8 {
 0% {
  width: 0.5em;
  box-shadow: 1em -0.5em rgba(225, 20, 98, 0.75), -1em 0.5em rgba(111, 202, 220, 0.75);
 }
 35% {
  width: 2.5em;
  box-shadow: 0 -0.5em rgba(225, 20, 98, 0.75), 0 0.5em rgba(111, 202, 220, 0.75);
 }
 70% {
  width: 0.5em;
  box-shadow: -1em -0.5em rgba(225, 20, 98, 0.75), 1em 0.5em rgba(111, 202, 220, 0.75);
 }
 100% {
  box-shadow: 1em -0.5em rgba(225, 20, 98, 0.75), -1em 0.5em rgba(111, 202, 220, 0.75);
 }
}
@keyframes after6 {
 0% {
  height: 0.5em;
  box-shadow: 0.5em 1em rgba(61, 184, 143, 0.75), -0.5em -1em rgba(233, 169, 32, 0.75);
 }
 35% {
  height: 2.5em;
  box-shadow: 0.5em 0 rgba(61, 184, 143, 0.75), -0.5em 0 rgba(233, 169, 32, 0.75);
 }
 70% {
  height: 0.5em;
  box-shadow: 0.5em -1em rgba(61, 184, 143, 0.75), -0.5em 1em rgba(233, 169, 32, 0.75);
 }
 100% {
  box-shadow: 0.5em 1em rgba(61, 184, 143, 0.75), -0.5em -1em rgba(233, 169, 32, 0.75);
 }
}
.loader {
 position: absolute;
 top: calc(50% - 1.25em);
 left: calc(50% - 1.25em);
}
.home{
  float: left;
  margin-left: 5vw;
  margin-top: 0.5vh;
}
.btn {
 padding: 1vmax;
 background: none;
 border: 2px solid #fff;
 cursor: pointer;
 position: relative;
 overflow: hidden;
 transition: all 0.3s;
 border-radius: 12px;
 box-shadow: 0 2px 0 2px #000;
 height: 9vh;
}
.home a{
  color: white;
  font-weight: bolder;
  font-size: 1.5vmax;
}
.btn:before {
 content: "";
 position: absolute;
 width: 100px;
 height: 120%;
 background-color: #ff6700;
 top: 50%;
 transform: skewX(30deg) translate(-150%, -50%);
 transition: all 0.5s;
}

.btn:hover {
 background-color: #4cc9f0;
 color: #fff;
 box-shadow: 0 2px 0 2px #0d3b66;
}
.btn:hover a{
  color: white;
}
.btn:hover::before {
 transform: skewX(30deg) translate(150%, -50%);
 transition-delay: 0.1s;
}

.btn:active {
 transform: scale(0.9);
}
.gu{
  background-color: grey;
  width: 8vw;
  height: 30vh;
  z-index: 1;
  border-radius: 10px;
  position: fixed;
  top: 40vh;
  left: -15vw;
  transition: 0.8s;
}
.gu li{
  text-align: center;
  height: 6vh;
}
.but1{
 width: 8vw;
 height:6vh;
 background: grey;
 border: none;
 border-radius: 5px;
 font-weight: bold;
 cursor: pointer;
 position: relative;
 z-index: 1;
 overflow: hidden;
}
.but1 a{
  color: white;
  font-size: 1vmax;
}
button a:hover {
 color: grey;
}
button:after {
 content: "";
 background: white;
 position: absolute;
 z-index: -1;
 left: -20%;
 right: -20%;
 top: 0;
 bottom: 0;
 transform: skewX(-45deg) scale(0, 1);
 transition: all 0.5s;
}
button:hover:after {
 transform: skewX(-45deg) scale(1, 1);
 -webkit-transition: all 0.5s;
 transition: all 0.5s;
}
.sb{
  position: fixed;
  top: 45vh;
  z-index: 0;
  width: 2vw;
  height: 6vh;
  opacity: 1;
  cursor: pointer;
}
.sb img{
    width: 8vw;
    height: 16vh;
    margin-left: -3.5vw;
}
.db:hover .gu{
  left: 0;
}
.db:hover .sb{
  opacity: 0;
}
.bian{
  width: 5vw;
  height: 100vh;
  position: fixed;
  top:10vh;
  z-index: -1;
  background-color: #d8ebff;
}
.bian1{
  width: 5vw;
  height: 100vh;
  position: fixed;
  top:10vh;
  z-index: -1;
  right: 0;
  background-color: #d8ebff;
}
#Abstract{
    font-size: 5vmax;
    display: flex;
    justify-content: center;
}   
.A1{
    font-size: 1.5vmax;
    width: 80vw;
    margin-left: 10vw;
    margin-top: 5vh;
}
.A2{
    font-size: 1.5vmax;
    width: 80vw;
    margin-left: 10vw;
    margin-top: 2vh;
}
.A3{
    font-size: 1.5vmax;
    width: 80vw;
    margin-left: 10vw;
    margin-top: 2vh;
}
#Ethical{
    font-size: 5vmax;
    display: flex;
    justify-content: center;
}
.E1{
    font-size: 1.5vmax;
    margin-left: 10vw;
    width: 80vw;
    margin-top: 5vh;
}
.E2{
    font-size: 1.8vmax;
    font-weight: 600;
    margin-left: 10vw;
    margin-top: 5vh;
}
.E3{
    font-size: 1.5vmax;
    margin-left: 10vw;
    width: 80vw;
}
.E4{
    font-size: 1.5vmax;
    margin-left: 10vw;
    width: 80vw;
    margin-top: 2vh;
}
.E5{
    font-size: 1.5vmax;
    margin-left: 10vw;
    width: 80vw;
    margin-top: 2vh;
}
.E6{
    font-size: 1.8vmax;
    margin-left: 10vw;
    font-weight: 600;
    margin-top: 5vh;
}
.E7{
    font-size: 1.5vmax;
    margin-left: 10vw;
    width: 80vw;
}
.E8{
    font-size: 1.8vmax;
    font-weight: 600;
    margin-left: 10vw;
    margin-top: 5vh;
}
.E9{
    font-size: 1.5vmax;
    margin-left: 10vw;
    width: 80vw;
}
#Legal{
    font-size: 5vmax;
    display: flex;
    justify-content: center;
    margin-top: 10vh;
}
.L1{
    font-size: 1.5vmax;
    width: 80vw;
    margin-left: 10vw;
    margin-top: 5vh;
}
.L2{
    font-size: 1.8vmax;
    margin-left: 10vw;
    font-weight: 600;
    margin-top: 5vh;
}
.L3{
    font-size: 1.5vmax;
    margin-left: 10vw;
    width: 80vw;
}
.L4{
    font-size: 1.5vmax;
    margin-left: 10vw;
    margin-top: 2vh;
    width: 80vw;
}
#Socialimplications{
    font-size: 5vmax;
    display: flex;
    justify-content: center;
    margin-top: 10vh;
}
.S1{
    font-size: 1.5vmax;
    width: 80vw;
    margin-left: 10vw;
    margin-top: 5vh;
}
#Conclusion{
    font-size: 5vmax;
    display: flex;
    justify-content: center;
}
#References{
    font-size: 2vmax;
    margin-left: 10vw;
}
.R1{
    font-size: 1vmax;
    font-weight: 50;
    margin-left: 10vw;
    width: 80vw;
    margin-top: 2vh;
}
.R2{
    font-size: 1vmax;
    margin-left: 10vw;
    width: 80vw;
    font-weight: 50;
    margin-top: 5vh;
}
.GG{
color: white;
font-size: 2.5vmax;
font-weight: 600;
position: fixed;
top: 2vh;
left: 25vw;
font-family: Verdana, Geneva, Tahoma, sans-serif;
}
.wheel-and-hamster {
  --dur: 1s;
  position: relative;
  margin-top: 30vh;
  margin-left: 42vw;
  width: 12em;
  height: 12em;
  font-size: 14px;
}

.wheel,
.hamster,
.hamster div,
.spoke {
  position: absolute;
}

.wheel,
.spoke {
  border-radius: 50%;
  top: 0;
  left: 0;
  width: 100%;
  height: 100%;
}

.wheel {
  background: radial-gradient(100% 100% at center,hsla(0,0%,60%,0) 47.8%,hsl(0,0%,60%) 48%);
  z-index: 2;
}

.hamster {
  animation: hamster var(--dur) ease-in-out infinite;
  top: 50%;
  left: calc(50% - 3.5em);
  width: 7em;
  height: 3.75em;
  transform: rotate(4deg) translate(-0.8em,1.85em);
  transform-origin: 50% 0;
  z-index: 1;
}

.hamster__head {
  animation: hamsterHead var(--dur) ease-in-out infinite;
  background: hsl(30,90%,55%);
  border-radius: 70% 30% 0 100% / 40% 25% 25% 60%;
  box-shadow: 0 -0.25em 0 hsl(30,90%,80%) inset,
		0.75em -1.55em 0 hsl(30,90%,90%) inset;
  top: 0;
  left: -2em;
  width: 2.75em;
  height: 2.5em;
  transform-origin: 100% 50%;
}

.hamster__ear {
  animation: hamsterEar var(--dur) ease-in-out infinite;
  background: hsl(0,90%,85%);
  border-radius: 50%;
  box-shadow: -0.25em 0 hsl(30,90%,55%) inset;
  top: -0.25em;
  right: -0.25em;
  width: 0.75em;
  height: 0.75em;
  transform-origin: 50% 75%;
}

.hamster__eye {
  animation: hamsterEye var(--dur) linear infinite;
  background-color: hsl(0,0%,0%);
  border-radius: 50%;
  top: 0.375em;
  left: 1.25em;
  width: 0.5em;
  height: 0.5em;
}

.hamster__nose {
  background: hsl(0,90%,75%);
  border-radius: 35% 65% 85% 15% / 70% 50% 50% 30%;
  top: 0.75em;
  left: 0;
  width: 0.2em;
  height: 0.25em;
}

.hamster__body {
  animation: hamsterBody var(--dur) ease-in-out infinite;
  background: hsl(30,90%,90%);
  border-radius: 50% 30% 50% 30% / 15% 60% 40% 40%;
  box-shadow: 0.1em 0.75em 0 hsl(30,90%,55%) inset,
		0.15em -0.5em 0 hsl(30,90%,80%) inset;
  top: 0.25em;
  left: 2em;
  width: 4.5em;
  height: 3em;
  transform-origin: 17% 50%;
  transform-style: preserve-3d;
}

.hamster__limb--fr,
.hamster__limb--fl {
  clip-path: polygon(0 0,100% 0,70% 80%,60% 100%,0% 100%,40% 80%);
  top: 2em;
  left: 0.5em;
  width: 1em;
  height: 1.5em;
  transform-origin: 50% 0;
}

.hamster__limb--fr {
  animation: hamsterFRLimb var(--dur) linear infinite;
  background: linear-gradient(hsl(30,90%,80%) 80%,hsl(0,90%,75%) 80%);
  transform: rotate(15deg) translateZ(-1px);
}

.hamster__limb--fl {
  animation: hamsterFLLimb var(--dur) linear infinite;
  background: linear-gradient(hsl(30,90%,90%) 80%,hsl(0,90%,85%) 80%);
  transform: rotate(15deg);
}

.hamster__limb--br,
.hamster__limb--bl {
  border-radius: 0.75em 0.75em 0 0;
  clip-path: polygon(0 0,100% 0,100% 30%,70% 90%,70% 100%,30% 100%,40% 90%,0% 30%);
  top: 1em;
  left: 2.8em;
  width: 1.5em;
  height: 2.5em;
  transform-origin: 50% 30%;
}

.hamster__limb--br {
  animation: hamsterBRLimb var(--dur) linear infinite;
  background: linear-gradient(hsl(30,90%,80%) 90%,hsl(0,90%,75%) 90%);
  transform: rotate(-25deg) translateZ(-1px);
}

.hamster__limb--bl {
  animation: hamsterBLLimb var(--dur) linear infinite;
  background: linear-gradient(hsl(30,90%,90%) 90%,hsl(0,90%,85%) 90%);
  transform: rotate(-25deg);
}

.hamster__tail {
  animation: hamsterTail var(--dur) linear infinite;
  background: hsl(0,90%,85%);
  border-radius: 0.25em 50% 50% 0.25em;
  box-shadow: 0 -0.2em 0 hsl(0,90%,75%) inset;
  top: 1.5em;
  right: -0.5em;
  width: 1em;
  height: 0.5em;
  transform: rotate(30deg) translateZ(-1px);
  transform-origin: 0.25em 0.25em;
}

.spoke {
  animation: spoke var(--dur) linear infinite;
  background: radial-gradient(100% 100% at center,hsl(0,0%,60%) 4.8%,hsla(0,0%,60%,0) 5%),
		linear-gradient(hsla(0,0%,55%,0) 46.9%,hsl(0,0%,65%) 47% 52.9%,hsla(0,0%,65%,0) 53%) 50% 50% / 99% 99% no-repeat;
}

/* Animations */
@keyframes hamster {
  from, to {
    transform: rotate(4deg) translate(-0.8em,1.85em);
  }

  50% {
    transform: rotate(0) translate(-0.8em,1.85em);
  }
}

@keyframes hamsterHead {
  from, 25%, 50%, 75%, to {
    transform: rotate(0);
  }

  12.5%, 37.5%, 62.5%, 87.5% {
    transform: rotate(8deg);
  }
}

@keyframes hamsterEye {
  from, 90%, to {
    transform: scaleY(1);
  }

  95% {
    transform: scaleY(0);
  }
}

@keyframes hamsterEar {
  from, 25%, 50%, 75%, to {
    transform: rotate(0);
  }

  12.5%, 37.5%, 62.5%, 87.5% {
    transform: rotate(12deg);
  }
}

@keyframes hamsterBody {
  from, 25%, 50%, 75%, to {
    transform: rotate(0);
  }

  12.5%, 37.5%, 62.5%, 87.5% {
    transform: rotate(-2deg);
  }
}

@keyframes hamsterFRLimb {
  from, 25%, 50%, 75%, to {
    transform: rotate(50deg) translateZ(-1px);
  }

  12.5%, 37.5%, 62.5%, 87.5% {
    transform: rotate(-30deg) translateZ(-1px);
  }
}

@keyframes hamsterFLLimb {
  from, 25%, 50%, 75%, to {
    transform: rotate(-30deg);
  }

  12.5%, 37.5%, 62.5%, 87.5% {
    transform: rotate(50deg);
  }
}

@keyframes hamsterBRLimb {
  from, 25%, 50%, 75%, to {
    transform: rotate(-60deg) translateZ(-1px);
  }

  12.5%, 37.5%, 62.5%, 87.5% {
    transform: rotate(20deg) translateZ(-1px);
  }
}

@keyframes hamsterBLLimb {
  from, 25%, 50%, 75%, to {
    transform: rotate(20deg);
  }

  12.5%, 37.5%, 62.5%, 87.5% {
    transform: rotate(-60deg);
  }
}

@keyframes hamsterTail {
  from, 25%, 50%, 75%, to {
    transform: rotate(30deg) translateZ(-1px);
  }

  12.5%, 37.5%, 62.5%, 87.5% {
    transform: rotate(10deg) translateZ(-1px);
  }
}

@keyframes spoke {
  from {
    transform: rotate(0);
  }

  to {
    transform: rotate(-1turn);
  }
}
.WRRRR{
  width: 100%;
  height: 100%;
  position: fixed;
  top: 0;
  left: 0;
  background-color: #98b6ec;
}
.BBBB{
  height: 50vh;
}
    </style>
</head>
<body>
    <div class="tp">
        <div class="sym"><img src="网站/队徽.png"></div>
<div class="loader"></div>
<div class="home"><button class="btn"><a href="index.html">HOME</a> </button></div>
<div class="GG">ELSI</div>
    <div class="menu">
        <div class="b1">MENU</div>
<div class="b2"><label class="bar" for="check">
<input type="checkbox" id="check">
<span class="top"></span>
<span class="middle"></span>
<span class="bottom"></span>
</label></div>
<ul class="cai">
  <li><button class="but"><a href="project.html">Project</a></button></li>
  <li><button class="but"><a href="design.html">Design</a></button></li>
  <li><button class="but"><a href="feasibility.html">Feasibility</a></button></li>
  <li><button class="but"><a href="method.html">Method</a></button></li>
  <li><button class="but"><a href="labbook.html">Labbook</a></button></li>
  <li><button class="but"><a href="result.html">Result</a></button></li>
  <li><button class="but"><a href="about us.html">About us</a></button></li>
  <li><button class="but"><a href="ELSI.html">ELSI</a></button></li>
  <li><button class="but"><a href="Future.html">Future</a></button></li>
</ul>
 </div>
    </div>
    <div class="db">
        <div class="dao">
        <ul class="gu">
    <li><button class="but1"><a href="#Abstract">Abstract</a></button></li>
    <li><button class="but1"><a href="#Ethical">Ethical</a></button></li>
    <li><button class="but1"><a href="#Legal">Legal</a></button></li>
    <li><button class="but1"><a href="#Socialimplications">Social implications</a></button></li>
    <li><button class="but1"><a href="#Conclusion">Equipments</a></button></li>
    </ul>
    </div><div class="sb"><img src="网站/jian.png"></div>
    </div>
    <div class="bian"></div>
    <div class="bian1"></div>
    <div class="ab">
        <h2 id="Abstract"><br>Abstract</h2>
        <div class="A1">In 1990, the National Institutes of Health (NIH) and the Department of Energy (DOE) established the Ethical, Legal, and Social Implications (ELSI) Research Program, with its functions and objectives being: to anticipate and address the impactof human genome sequencing on individuals and society; to scrutinize the ethical, legal, and social consequences of human genome sequencing; to stimulate public discourse on such issues; and to promote the development of policies and programs that ensure the use of information in a manner consistent with the interest of individuals and  the society.</div>
        <div class="A2">The ELSI Research Program has shown a profound impact. It has made the general public aware of the various ethical issues brought about by modern scientific and technological advancements, including potential ethical issues that may arise during the scientific research process, as well as the potential impacts of scientific research on nature and society. At the same time, it has made society aware of the scientific community's emphasis on the various consequences brought about by scientific development.</div>
        <div class="A3">The advent of DNA origami technology has revolutionized the field of nanorobotics, enabling the construction of sophisticated nanoscale structures with potential applications in drug delivery, molecular computing, and diagnostics. As these technologies advanced, they raise a plethora of ethical, legal, and social implications (ELSI) that demand thorough examination. This study aims to provide a comprehensive analysis of the ELSI aspects associated with the development and application of DNA origami nanorobots.</div>
</div>
<div class="ET">
    <h2 id="Ethical"><br>Ethical</h2>
    <div class="E1">The Ethics section typically facilitates ensuring that research is ethically acceptable and garners societal trust and support.</div>
    <div class="E2">Research Ethics </div>
    <div class="L4">• Autonomy of Participants: No human subjects were involved in the laboratory procedures. Interviews conducted under the Social Implications section were all obtained with informed consent. </div>
    <div class="L4">• Informed Consent: Participants were fully informed about the purposes of the interviews.</div>
    <div class="L4">• Privacy Protection: To safeguard the privacy of participants, we have refrained from disclosing their personal information on our website.</div>
    <div class="L2">Equity and Justice </div>
    <div class="L4">We strive for equity and fairness in both research outcomes and processes, with no form of discrimination or bias present in the research conduct. </div>
    <div class="L2">Transparency</div>
    <div class="L4">Our research process is characterized by transparency, with raw data being publicly accessible on our website. Throughout the experimental procedures, the laboratory is subject to external supervision and scrutiny by instructors and other qualified individuals at any time.</div>
</div>
<div class="LE">
    <h2 id="Legal"><br>Legal</h2>
    <div class="L1">The Legal section ensures that our research is lawful, compliant with institutional, national, and international regulations, and contributes to conducting research within a reasonable scope that does not threaten societal security.</div>
    <div class="L2">Biosafety</div>
    <div class="L3">Ensuring biosafety during the research process involves preventing potential hazards to the environment and human health. </div>
    <div class="L4">• The plasmid scaffold we utilize is M18mp13 p7249, which is non-infectious to humans or any other organisms. </div>
    <div class="L4">• When preparing agarose gels for DNA electrophoresis, we opt for non-toxic red fluorescent dyes in place of ethidium bromide, which are non-toxic and non-mutagenic.</div>
    <div class="L4">• In verifying the functionality of light-controlled switches, we employed a near-infrared laser emitter. Higher power near-infrared lasers can damage vision, cause skin burns, and ignite fires. Therefore, we strictly adhere to the user manual and university regulations, using near-infrared lasers within a safe power range. </div>
    <div class="L4">• During electron microscopy sample preparation, we used negative staining techniques, which involve the use of uranyl acetate, a highly hazardous reagent to biological entities. Consequently, the corresponding experiments are conducted under strict experimental records and supervision to ensure the use and disposal of highly toxic reagents comply with university regulations.</div>
    <div class="L2">Information Security</div>
    <div class="L4">We ensure the security of data and information, including experimental data and potentially involved genomic sequence information. </div>
    <div class="L4"> • The sequence of the plasmid scaffold M18mp13 p7249 we use is publicly available (ordered from Biorule), and there is no risk of revealing sensitive personal or genetic information. </div>
    <div class="L4">• The staple strands are designed using the caDNAno software, which, to our knowledge, does not carry genetic information or the risk of information leakage.</div>
    <div class="L2">Copyright</div>
    <div class="L4">DNA sequences, as part of the research outcomes in the field of DNA origami, may involve patent and copyright issues. </div>
    <div class="L4">• We ensure that there is no unauthorized use of any patented technology during the research process. We utilize publicly available software such as caDNAno and CanDo.</div>
    <div class="L2">Clinical Safety</div>
    <div class="L4">Our research does not involve any clinical data. Should it be applied to clinical aspects in the future, it should strictly comply with relevant laws, regulations, and ethical standards, clarifying the design, approval, implementation, and monitoring processes of clinical trials to ensure compliance with GCP (Good Clinical Practice) standards.</div>
</div>
<div class="SO">
    <h2 id="Socialimplications"><br>Social implications</h2>
    <div class="S1">In the Social Implications section, we intend to outline the potential audience and relevant demographics for Doara, presenting our interviews and their thoughts on the potential social impacts of Doara through a Q&A format. To protect the privacy of the interviewees, we do not  display their personal information on our website. If interested in this section, please contact cuitong0808@163.com.</div>
    <div class="L2">Potential Social Aspects Affected</div>
    <div class="L4">Our team conducted a brainstorming session to list the following social aspects that may be affected by Doara: government (formulating relevant policies), biotech companies (developing products), healthcare industry (applying products), patients (using products), and educational sector. We then conducted interviews with practitioners from these industries and briefly described our interviews. We hope that the concerns and issues they raised during the interviews can provide guidance for the ELSI research of this project.</div>
    <div class="L2">Government Officials</div>
    <div class="L4">Q: (Briefly introduced Doara) So, what positive impacts do you think this technology could bring to the group you represent/your work?</div>
    <div class="L4"> From a social planning perspective, if this therapy can improve patients' medical experiences and reduce their suffering, then it has value in being implemented. Additionally, as a new potential means of precision medicine/diagnosis, it may reduce healthcare expenditure, which is also very beneficial.</div>
    <div class="L4"> From your perspective, do you think this technology has any negative social impacts? What potential risks do you see?</div>
    <div class="L4"> Many technologies with clinical application prospects face challenges in translation to practical use. The costs associated with implementing could be very high, which is a concern that must be considered.</div>
    <div class="L2">Biotech Businesspeople</div>
    <div class="L4">Q: (Briefly introduced Doara) So, what positive impacts do you think this technology could bring to the group you represent/your work?</div>
    <div class="L4">A: In my opinion, technological progress is definitely more beneficial  The application of technology in the medical field for disease detection or direct destruction of pathogens is a beneficial direction.</div>
    <div class="L4">Q: From your perspective, do you think this technology has any negative social impacts? What potential risks do you see?</div>
    <div class="L4">A: I believe that the control systems for nanorobots are still very limited, and even the control systems for larger robots are not perfect. They are not sensitive enough, and perhaps future applications of artificial intelligence will improve this. On the other hand, if this technology is applied to the military, it could also harm people's privacy or safety.</div>
    <div class="L2">Physicians</div>
    <div class="L4">Q: (Briefly introduced Doara) So, what positive impacts do you think this technology could bring to the group you represent/your work?</div>
    <div class="L4">A: I believe this technology can greatly assist in precision medicine. More accurate and convenient diagnostic and therapeutic tools are very much needed in modern medicine.</div>
    <div class="L4">Q: From your perspective, do you think this technology has any negative social impacts? What potential risks do you see?</div>
    <div class="L4">A: In my opinion safety is always the most concerning issue. The cost of nanorobots going out of control in clinical scenarios would be very high.</div>
<div class="L2">Patients</div>
<div class="L4">Q: (Briefly introduced Doara) So, what positive impacts do you think this technology could bring to the group you represent/your work?</div>
<div class="L4">A: Is it a new kind of medicine?</div>
<div class="L4">Q： No, Doara is actually a delivery platform. In layman's terms, it has the potential to be a therapeutic, diagnostic, and transportation tool. Or you can imagine nanorobots that can wander in your body, performing various functions among cells. What expectations do you have for them?</div>
<div class="L4">A: Actually, I am very excited about this technology! There are still many diseases that current medical treatments cannot cure or are too costly. I hope nanorobots can cure diseases that were previously incurable or have fewer side effects than current medications.</div>
<div class="L4">Q: From your perspective, do you think this technology has any negative social impacts? What potential risks do you see?</div>
<div class="L4">A: I am  concerned about whether this new technology is mature and safe enough. If it fails to function properly, could it cause damage to ourbody? I would definitely feel anxious when trying this therapy.</div>
<div class="L2">Education Professionals (An Elementary School Teacher)</div>
<div class="L4">Q: (Briefly introduced Doara) So, what positive impacts do you think this technology could bring to the group you represent/your work?</div>
<div class="L4">A: I think this cool new technology can spark students' interest in science. It can attract students who love science and help them understand the professions they might pursue.</div>
<div class="L4">Q: From your perspective, do you think this technology has any negative social impacts? What potential risks do you see?</div>
<div class="L4">A: I can't really think of any risk that this new technology could bring to the education industry. I believe new technology is a reflection of societal and human progress, which is what education aims to teach children. Perhaps there might be issues with safety or social risks, but from an educational standpoint, technological innovation is generally worth encouraging.</div>
<div class="L2">Summary</div>
<div class="L4">The above interview content may include the views of various sectors of society on Doara. In summary: the main concerns people have include the potential progress that it could bring to clinical therapeutic methods and worries about its safety risks, which remind us to pay particular attention to the verification and evaluation of these aspects.</div>
</div>
<div class="CL">
    <h2 id="Conclusion"><br>Conclusion</h2>
    <div class="S1">As the field of DNA origami nanotechnology advances with groundbreaking developments, we are confronted with a complex array of ethical, legal, and social issues. This study delves into these ELSI concerns, aiming to provide the scientific community, policymakers, and the public with a comprehensive perspective to understand and address these challenges.We call for a collective effort from the scientific community, policymakers, and the public to ensure that the development of these technologies benefits humanity while respecting ethical principles and societal values. We look forward to future research continuing to explore these ELSI issues and providing guidance and insights towards achieving this goal.</div>
</div>
<div class="RF">
    <h2 id="References"><br>References</h2>
    <div class="L2">Chemical safety</div>
    <div class="R1">[1]   Regulations on the Safety Management of Hazardous Chemicals (State Council Order No. 344, 2013 Revision)</div>
    <div class="R1">《危险化学品安全管理条例》国务院令第344号 2013年修正</div>
    <div class="R1">http://www.gov.cn/gongbao/content/2002/content_61929.htm</div>
    <div class="R2">[2]   Regulations on the Control of Precursors for the Manufacture of Narcotic Drugs and Psychotropic Substances (State Council Order No. 445, 2018 Revision)</div>
    <div class="R1">《易制毒化学品管理条例》国务院令第445号 2018年修正</div>
    <div class="R1">http://www.gov.cn/gongbao/content/2005/content_91170.htm</div>
    <div class="R2">[3]   Administrative Measures for Toxic Drugs Used in Medical Treatment (State Council Order No. 23)</div>
    <div class="R1">《医疗用毒性药品管理办法》国务院令第23号</div>
    <div class="R1">http://www.moh.gov.cn/mohzcfgs/pfg/200804/18300.shtml</div>
    <div class="L2">Safety of radiation</div>
    <div class="R2">[4]   Classification Method for Radioactive Sources (Announcement No. 62, 2005, State Environmental Protection Administration)</div>
    <div class="R1">《放射源分类办法》国家环境保护总局公告 2005年 第62号</div>
    <div class="R1">http://www.gov.cn/gzdt/2005-12/28/content_140242.htm  </div>
    <div class="R2">[5]   Classification Method for Radiation Apparatus (Announcement No. 26, 2006, State Environmental Protection Administration)</div>
    <div class="R1">《射线装置分类办法》环境保护总局公告 2006年 第26号</div>
    <div class="R1">http://www.zhb.gov.cn/info/gw/gg/200605/t20060530_77223.htm  </div>
    <div class="L2">Special purpose equipment</div>
    <div class="R2">[6]   Supervision and Administration Measures for Special Equipment Operators (Order No. 70, General Administration of Quality Supervision, Inspection and Quarantine, 2011 Revision)</div>
    <div class="R1">《特种设备作业人员监督管理办法》质量监督检验检疫总局令第70号 2011年修改  </div>
    <div class="R1">http://www.gov.cn/flfg/2011-05/24/content_1870206.htm </div>
    <div class="R2">[7]   Regulations on the Reporting and Investigation of Special Equipment Accidents (Order No. 115, General Administration of Quality Supervision, Inspection and Quarantine)</div>
    <div class="R1">《特种设备事故报告和调查处理规定》质量监督检验检疫总局令第115号</div>
    <div class="R1">http://www.gov.cn/flfg/2009-07/10/content_1361894.htm  </div>
    <div class="L2">Protection of the environment</div>
    <div class="R2">[8]   Environmental Protection Law of the People's Republic of China (Chairman's Order No. 22)</div>
    <div class="R1">《中华人民共和国环境保护法》主席令第二十二号  </div>
    <div class="R1">http://www.gov.cn/fwxx/bw/hbzj/content_810469.htm </div>
    <div class="R2">[9]   Environmental Impact Assessment Law of the People's Republic of China (Chairman's Order No. 77)</div>
    <div class="R1">《中华人民共和国环境影响评价法》主席令第七十七号  </div>
    <div class="R1">http://www.hbepb.gov.cn/hbfg/fl/200606/t20060606_8646.html</div>
    <div class="R2">[10]   National Catalogue of Hazardous Wastes (Ministry of Environmental Protection Order No. 1)</div>
    <div class="R1">《国家危险废物名录》环境保护部第1号  </div>
    <div class="R1">http://www.gov.cn/flfg/2008-06/17/content_1019136.htm  </div>
    <div class="L2">Special thanks</div>
    <div class="R1">iGEM2024 Jilin-China Project Safty Form</div>
    <div class="R1">https://teams.igem.org/5446/safety/905a6e1c-6acc-41a8-8d06-6949d03f3325</div>
</div>
<div class="BBBB"></div>
<div class="WRRRR">
  <div aria-label="Orange and tan hamster running in a metal wheel" role="img" class="wheel-and-hamster">
    <div class="wheel"></div>
    <div class="hamster">
      <div class="hamster__body">
        <div class="hamster__head">
          <div class="hamster__ear"></div>
          <div class="hamster__eye"></div>
          <div class="hamster__nose"></div>
        </div>
        <div class="hamster__limb hamster__limb--fr"></div>
        <div class="hamster__limb hamster__limb--fl"></div>
        <div class="hamster__limb hamster__limb--br"></div>
        <div class="hamster__limb hamster__limb--bl"></div>
        <div class="hamster__tail"></div>
      </div>
    </div>
    <div class="spoke"></div>
  </div>
</div>
<script src="网站/jquery/jquery-3.7.1.js"></script>
<script src="网站/jquery/jquery-3.7.1.min.js"></script>
<script>
  $(window).on("load",function(){
    $(".WRRRR").fadeOut("slow");
  });
</script>
<script src="script.js"></script>
</body>
</html>